Selling Your Dental Practice to a DSO: EBITDA, Multiples, and the $2M Mistake
Most dental practice owners only sell once. They've built the practice for 20 or 30 years, they get an unsolicited offer from a DSO that sounds incredible, and they accept it — usually after running the numbers past their CPA and a buddy who sold a year ago. What they don't realize is that the offer was engineered to look attractive while quietly leaving 20-40% of their practice's value on the table. The single biggest predatory move DSOs make isn't the multiple — it's the EBITDA number itself. Get talked out of $200K of legitimate addbacks at a 7× multiple, and the dentist just lost $1.4 million without knowing it. 🎯 What you'll learn: What EBITDA actually means in plain English (absentee owner profit) How private equity makes money on dental practices (the buy-low/sell-high arbitrage cycle) The difference between joint venture equity and holding company equity in DSO deals DSO 1.0 vs. 2.0: why the bad-rep era is over and what changed Why valuations peaked in 2021-2022, normalized in 2023-2024, and stabilized in 2025 What makes a Class A acquisition target (geography, key-man risk, EBITDA size, payer mix) The 60-mile-from-major-metro rule for maximum demand Why single-doctor super-producer practices get lower offers (and how to fix it) The $500K EBITDA threshold where DSO demand significantly accelerates Why infrastructure erodes EBITDA (fewer locations + higher EBITDA beats more locations + less) Why payer mix above 25% Medicaid hurts demand (40% in pedo) Real numbers: 6× to 9× EBITDA range for class A general dentistry practices Earnouts vs. holdbacks: what they are and how they're negotiated How "deal fatigue" wipes out millions when you don't have representation The case study: $6.8M unsolicited offer became $9M closed deal — same DSO ⏱ Chapters 0:00 Intro 2:50 Meet Brandon Monreef, Principal and CEO of McLaren and Associates 4:34 Defining EBITDA: absentee owner profit explained 7:18 What private equity actually is (and how the fund cycle works) 8:54 The recap event explained 10:01 Scott's plain-English EBITDA recap 12:54 The leverage math: how PE turns 2× into 4× through debt 14:42 Joint venture equity vs. holding company equity 15:51 DSO 1.0: why the early consolidation gave DSOs a bad name 16:50 DSO 2.0: the provider-centric pivot starting 7-10 years ago 18:50 The rise of the multi-location group practice 20:14 Pre-COVID DSO market conditions 21:09 The 21-22 valuation peak (30-50% increase) 22:35 The 2023-2024 reckoning and market normalization 23:32 Today's market: declining rates, renewed PE interest 25:36 Q1 2025 recap activity (MB2 and others) 27:14 Why deal structures evolved post-2022 (more earnouts, more holdbacks) 28:04 Earnouts vs. holdbacks: what each actually means 30:00 What DSOs are looking for in a Class A target 30:11 The 60-mile rule and geographic demand 31:01 Key-man risk and the multi-doctor advantage 32:25 Specialty DSO trends (pedo, ortho, OMS demand) 33:35 Single-doctor super-producer strategy options 35:44 Geography: why tertiary markets still get bids 37:26 The $500K EBITDA threshold and demand acceleration 39:07 Why DSOs scrutinize same-store sales growth post-recap 41:34 What impacts the EBITDA multiple 42:35 Why every $1 of EBITDA = $7+ of practice value 43:14 The predatory EBITDA narrative: $1M+ left on the table 44:42 Cleaning up financials before going to market 45:53 The $800K of practice cuts case study (worth $5M extra value) 48:02 Multiple drivers: doctors, locations, geography, infrastructure 50:34 Why more locations isn't always better (infrastructure erodes EBITDA) 51:34 Payer mix and Medicaid exposure thresholds 54:27 Personality: why PE pays more when they like you 54:43 Aligning incentives with associates and minority partners before sale 56:51 DSO deal structure: cash + equity + earnout combinations 59:21 Keys to maximizing your sale outcome 1:01:02 The 1-2 year practice management coaching prep window 1:03:48 Why never to respond to an unsolicited offer 1:05:34 The buddy referral conflict of interest 1:06:12 The bid process and creating a competitive environment 1:09:00 The case study: $6.8M offer became $9M closed deal (same DSO, $2.2M premium) 1:12:00 Deal fatigue and how representation prevents it 🔗 Schedule a confidential discovery call with Brandon: scan the QR code in the video, or visit mclerassociates.com 🎙 Related: How Dentists Get 100% Financing + 2.5 Years Interest-Only on Startup Loans (Huntington Bank) • Aligning With the Right Capital Partner - ... 🎟 Save 25% on Scott Leune's live training — practice management mastery, multi-location, startups, and acquisitions: scottleune.com 🔔 Subscribe to the Dental CEO Podcast — text "podcast" to 48659 Subscribe for real numbers and real frameworks from someone who's helped open 200+ dental practices. #DSOSale #DentalDSO #DentalEBITDA #DentalPracticeSale #DentalPracticeValuation #McLarenAndAssociates #ScottLeune #PracticeMastery #DentalCEO